GOING BEYOND THE EXPECTED

Research

National Institutes of Health executes $7 million for UGA-led influenza research center studies

December 17, 2024

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, recently exercised multiple options totaling more than $7 million to the University of Georgia Center for Influenza Disease and Emergence Research (CIDER)

Learn More

Parkinson’s is the Disease. He Could be the Cure.

December 6, 2024

About 1 million Americans have Parkinson’s, and more than 50,000 new cases are diagnosed annually. University of Georgia Professor Anumantha Kanthasamy has a plan to fight back

Learn More

UGA VetMed & Parkinson’s Research: What’s the Connection?

December 6, 2024

If you're asking yourself why a veterinary school is home to a world-class center for Parkinson's research, you're not alone. Discover the answer here!

Learn More

UGA’s Precision One Health Initiative Improves Animal and Human Health by Developing Alternative Models of Disease

December 6, 2024

Researchers at the UGA VetMed aim to improve health for man & man's best friend, using organoids. This study and others like it embody the mission of the UGA Precision One Health Initiative.

Learn More

UGA VetMed Leads FDA Partnership to Safeguard U.S. Dairy Supplies

December 5, 2024

UGA is one of five institutions in the nation collaborating with the FDA to ensure the safety of U.S. dairy products during the avian influenza outbreak.

Learn More

Meet the Director: UGA Center for Vaccines and Immunology

December 5, 2024

Mark Tompkins is the Director of the UGA Center for Vaccines & Immunology. He oversees a team of premier researchers who are pioneering vaccine development and the study of pathogens. CVI researchers work alongside national and international partners at academic, governmental, and private institutions to improve public health equity and vaccine availability so that they can be prepared for another pandemic.

Learn More

Meet the Director: The Isakson Center for Neurological Disease Research

December 4, 2024

Anumantha Kanthasamy is the inaugural Director of the Isakson Center for Neurological Disease Research, a state-of-the-art facility staffed by an innovative, interdisciplinary network of renowned researchers who are leading the way in deciphering underlying mechanisms, developing early diagnostic biomarkers, and developing novel therapeutic strategies for the treatment of Parkinson’s Disease and other neurodegenerative diseases, including Alzheimer’s disease-related dementia.

Learn More

1min read

CVM Bee Medicine Program Conducting Clinical Trials for Bee Vaccine

April 24, 2023

UGA’s College of Veterinary Medicine is working with Dalan Animal Health to conduct field trials on the world’s first ever bee vaccine.

Learn More

1min read

UGA’s intranasal COVID vaccine shows promise.

August 16, 2022

An engineered dog virus shows promise to promote an immune response

Learn More

2min read

Congress looks to UGA CVM to push Parkinson’s Research Forward.

August 8, 2022

Funding made in tribute to the late John H. ‘Johnny’ Isakson will provide additional resources to UGA’s brain sciences program.

Learn More

GOING BEYOND THE EXPECTED